04.08.2023 – Welcoming Dr. Raquel Sousa to abc biopply

We are delighted to introduce Dr. Raquel Sousa as the newest addition to our abc biopply team. Dr. Sousa will be joining us as a Research and Development Scientist at our laboratory in Cham, starting on November 1st. Her expertise will strengthen our laboratory group, focusing on preclinical study projects and advancing our 3D assay portfolio. We are excitedly looking forward to the valuable contributions Dr. Sousa will make towards our organization's growth and success.

Read more

28.06.2022 – WEBINAR: A Novel 3D High Throughput Co-culture System for Multiple Myeloma

In collaboration with the American Physiological Society (APS) and our American partner nanoscaleLABS, abc biopply is organizing a webinar on the use of 3D CoSeedis™ in high throughput ex vivo propagation of multiple myeloma cells. Dr Johannes Waldschmidt and Dr Andreas Thomsen from the University of Freiburg in Germany together with Dr Marco Leu from abc biopply will discuss the importance of reliable 3D preclinical disease models in accurate and predictive compound testing.

Read more

09.12.2021 - Making 3D cell culture a part of HTS standard applications

abc biopply and SEED Bioscienses have recently started to co-develop an inovative new method to make 3D cell cultures assessible for HTS applications. In this collaboration, abc biopply provides highly homogenous and uniform 3D cultures in large quantities using its prorietary 3D CoSeedis™ platform whereas SEED Bioscienses uses its DISPENCELL technology to disperse them into HTS compatible multi-well plates.

Finally, HTS users will gain access to a reliable source of high quality 3D cultures in sufficient quantities to reach unprecedented efficacy in HTS of 3D cultures.

Read more

Contact us